Your browser doesn't support javascript.
loading
GIGYF1 disruption associates with autism and impaired IGF-1R signaling.
Chen, Guodong; Yu, Bin; Tan, Senwei; Tan, Jieqiong; Jia, Xiangbin; Zhang, Qiumeng; Zhang, Xiaolei; Jiang, Qian; Hua, Yue; Han, Yaoling; Luo, Shengjie; Hoekzema, Kendra; Bernier, Raphael A; Earl, Rachel K; Kurtz-Nelson, Evangeline C; Idleburg, Michaela J; Madan-Khetarpal, Suneeta; Clark, Rebecca; Sebastian, Jessica; Fernandez-Jaen, Alberto; Alvarez, Sara; King, Staci D; Ramos, Luiza Lp; Santos, Mara Lucia Sf; Martin, Donna M; Brooks, Dan; Symonds, Joseph D; Cutcutache, Ioana; Pan, Qian; Hu, Zhengmao; Yuan, Ling; Eichler, Evan E; Xia, Kun; Guo, Hui.
Afiliação
  • Chen G; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Yu B; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Tan S; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Tan J; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Jia X; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Zhang Q; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Zhang X; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Jiang Q; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Hua Y; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Han Y; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Luo S; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Hoekzema K; Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
  • Bernier RA; Department of Psychiatry, University of Washington, Seattle, Washington, USA.
  • Earl RK; Department of Psychiatry, University of Washington, Seattle, Washington, USA.
  • Kurtz-Nelson EC; Department of Psychiatry, University of Washington, Seattle, Washington, USA.
  • Idleburg MJ; Department of Medical Genetics, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Madan-Khetarpal S; Department of Medical Genetics, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Clark R; Department of Medical Genetics, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Sebastian J; Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Fernandez-Jaen A; Department of Pediatric Neurology, Hospital Universitario Quirónsalud, School of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • Alvarez S; Department of Genomics and Medicine, Genomics and Medicine, NIMGenetics, Madrid, Spain.
  • King SD; Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
  • Ramos LL; Mendelics Genomic Analysis, Sao Paulo, Brazil.
  • Santos MLS; Neurogenetics Unit, Department of Neurology, University of Sao Paulo, Sao Paulo, Brazil.
  • Martin DM; Neuropediatric Division, Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
  • Brooks D; Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Symonds JD; Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Cutcutache I; Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, United Kingdom.
  • Pan Q; Translational Medicine, UCB Pharma, Slough, United Kingdom.
  • Hu Z; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Yuan L; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Eichler EE; Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
  • Xia K; Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
  • Guo H; Howard Hughes Medical Institute, University of Washington, Seattle, Washington, USA.
J Clin Invest ; 132(19)2022 10 03.
Article em En | MEDLINE | ID: mdl-35917186
Autism spectrum disorder (ASD) represents a group of neurodevelopmental phenotypes with a strong genetic component. An excess of likely gene-disruptive (LGD) mutations in GIGYF1 was implicated in ASD. Here, we report that GIGYF1 is the second-most mutated gene among known ASD high-confidence risk genes. We investigated the inheritance of 46 GIGYF1 LGD variants, including the highly recurrent mutation c.333del:p.L111Rfs*234. Inherited GIGYF1 heterozygous LGD variants were 1.8 times more common than de novo mutations. Among individuals with ASD, cognitive impairments were less likely in those with GIGYF1 LGD variants relative to those with other high-confidence gene mutations. Using a Gigyf1 conditional KO mouse model, we showed that haploinsufficiency in the developing brain led to social impairments without significant cognitive impairments. In contrast, homozygous mice showed more severe social disability as well as cognitive impairments. Gigyf1 deficiency in mice led to a reduction in the number of upper-layer cortical neurons, accompanied by a decrease in proliferation and increase in differentiation of neural progenitor cells. We showed that GIGYF1 regulated the recycling of IGF-1R to the cell surface. KO of GIGYF1 led to a decreased level of IGF-1R on the cell surface, disrupting the IGF-1R/ERK signaling pathway. In summary, our findings show that GIGYF1 is a regulator of IGF-1R recycling. Haploinsufficiency of GIGYF1 was associated with autistic behavior, likely through interference with IGF-1R/ERK signaling pathway.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtorno do Espectro Autista Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtorno do Espectro Autista Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China